Barclays Issues Pessimistic Forecast for Procter & Gamble (NYSE:PG) Stock Price

Procter & Gamble (NYSE:PGGet Free Report) had its target price reduced by Barclays from $163.00 to $155.00 in a report issued on Friday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s price target points to a potential downside of 3.93% from the stock’s previous close.

Several other equities research analysts have also commented on PG. UBS Group dropped their price objective on shares of Procter & Gamble from $196.00 to $189.00 and set a “buy” rating on the stock in a research note on Thursday. DA Davidson restated a “buy” rating and set a $209.00 price objective on shares of Procter & Gamble in a research report on Friday, December 27th. Piper Sandler began coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price objective on the stock. Evercore ISI upped their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $179.65.

Check Out Our Latest Stock Report on Procter & Gamble

Procter & Gamble Price Performance

PG stock opened at $161.35 on Friday. Procter & Gamble has a 12-month low of $146.28 and a 12-month high of $180.43. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The firm’s 50-day moving average price is $169.19 and its two-hundred day moving average price is $169.38. The stock has a market capitalization of $379.98 billion, a price-to-earnings ratio of 27.82, a PEG ratio of 3.41 and a beta of 0.45.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter in the previous year, the company earned $1.83 earnings per share. Procter & Gamble’s quarterly revenue was down .6% on a year-over-year basis. As a group, equities analysts predict that Procter & Gamble will post 6.93 earnings per share for the current year.

Insider Transactions at Procter & Gamble

In related news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the transaction, the insider now owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 75,439 shares of company stock worth $13,317,460. 0.18% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $28,000. RPg Family Wealth Advisory LLC acquired a new stake in Procter & Gamble in the 3rd quarter worth approximately $33,000. Quest Partners LLC acquired a new stake in Procter & Gamble during the 2nd quarter valued at approximately $36,000. Costello Asset Management INC lifted its stake in Procter & Gamble by 2,142.9% during the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company’s stock valued at $54,000 after acquiring an additional 300 shares during the period. Finally, William B. Walkup & Associates Inc. acquired a new stake in Procter & Gamble during the 2nd quarter valued at approximately $58,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Stories

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.